Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management
- PMID: 16893345
- DOI: 10.1586/14737175.6.8.1173
Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management
Abstract
Blood pressure disorders are highly prevalent in the course of Parkinson's disease (PD). They relate to autonomic failure and are frequently associated with orthostatic hypotension, postprandial hypotension and supine hypertension. Supine hypertension, which may concern up to 50% of patients with PD and autonomic failure, is driven by residual sympathetic activity and changes in sensitivity of vascular adrenergic receptors. It can also be induced or worsened by antihypotensive drugs. Even if little data is available, a set of arguments suggests that supine hypertension sometimes requires treatment. This review will focus on recent data on the pathophysiology and the management of supine hypertension in the context of its association with orthostatic hypotension.
Similar articles
-
Pharmacology of orthostatic hypotension in Parkinson's disease: from pathophysiology to management.Expert Rev Cardiovasc Ther. 2004 May;2(3):393-403. doi: 10.1586/14779072.2.3.393. Expert Rev Cardiovasc Ther. 2004. PMID: 15151485 Review.
-
[Orthostatic hypotension and supine hypertension in pure autonomic failure].Ital Heart J Suppl. 2004 Nov;5(11):879-83. Ital Heart J Suppl. 2004. PMID: 15633433 Italian.
-
Orthostatic hypotension due to autonomic disorders in the hypertension clinic.Am J Hypertens. 2006 Mar;19(3):319-26. doi: 10.1016/j.amjhyper.2005.09.019. Am J Hypertens. 2006. PMID: 16500521 Review.
-
[Orthostatic hypotension and supine hypertension in primary autonomic failure. Pathophysiology, diagnosis and treatment].Kardiol Pol. 2010 Sep;68(9):1057-63. Kardiol Pol. 2010. PMID: 20859904 Review. Polish.
-
Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure.Hypertension. 2006 Mar;47(3):522-6. doi: 10.1161/01.HYP.0000199982.71858.11. Epub 2006 Jan 3. Hypertension. 2006. PMID: 16391172 Clinical Trial.
Cited by
-
Effects of Tyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.Mov Disord Clin Pract. 2014 Oct 23;1(4):348-353. doi: 10.1002/mdc3.12082. eCollection 2014 Dec. Mov Disord Clin Pract. 2014. PMID: 30363894 Free PMC article.
-
The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson's Disease: What We Know and Where to Go.Aging Dis. 2021 Oct 1;12(7):1675-1692. doi: 10.14336/AD.2021.0214. eCollection 2021 Oct. Aging Dis. 2021. PMID: 34631214 Free PMC article. Review.
-
Clinostatic hypertension and orthostatic hypotension.Clin Cardiol. 2010 Jun;33(6):E10-5. doi: 10.1002/clc.20722. Clin Cardiol. 2010. PMID: 20552588 Free PMC article.
-
Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease.Neurology. 2012 Sep 25;79(13):1323-31. doi: 10.1212/WNL.0b013e31826c1acd. Epub 2012 Sep 12. Neurology. 2012. PMID: 22972639 Free PMC article.
-
Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials.Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD008535. doi: 10.1002/14651858.CD008535.pub2. Cochrane Database Syst Rev. 2011. PMID: 22071852 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical